Omniab Inc Stock Analysis

OmniAb Stock Analysis Notes

About 69.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.63. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. OmniAb Inc recorded a loss per share of 0.62. The entity had not issued any dividends in recent years. OmniAb, Inc., a biotechnology company, provides therapeutic antibody discovery technologies in the United States. The company was founded in 2012 and is headquartered in Emeryville, California. Amniab operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 74 people. To find out more about OmniAb Inc contact Matthew Foehr at 510 250 7800 or learn more at https://www.omniab.com.

OmniAb Inc Investment Alerts

OmniAb Inc Upcoming and Recent Events

OmniAb Largest EPS Surprises

View All Earnings Estimates

OmniAb Environmental, Social, and Governance (ESG) Scores

OmniAb Stock Institutional Investors

Note, although OmniAb's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

OmniAb Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 474.37 M.

OmniAb Profitablity

Management Efficiency

OmniAb Inc has return on total asset (ROA) of (0.1376) % which means that it has lost $0.1376 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2045) %, meaning that it created substantial loss on money invested by shareholders. OmniAb's management efficiency ratios could be used to measure how well OmniAb manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.39. The current Return On Capital Employed is estimated to decrease to -0.21. As of now, OmniAb's Other Assets are increasing as compared to previous years. The OmniAb's current Intangibles To Total Assets is estimated to increase to 0.87, while Total Assets are projected to decrease to under 364.9 M.

Technical Drivers

As of the 25th of November, OmniAb holds the Variance of 7.05, risk adjusted performance of 9.0E-4, and Coefficient Of Variation of (12,258). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of OmniAb, as well as the relationship between them.

OmniAb Inc Price Movement Analysis

OmniAb Inc Insider Trading Activities

OmniAb Outstanding Bonds

OmniAb Predictive Daily Indicators

OmniAb Corporate Filings

OmniAb Forecast Models

OmniAb's time-series forecasting models are one of many OmniAb's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary OmniAb's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how OmniAb prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling OmniAb shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as OmniAb. By using and applying OmniAb Stock analysis, traders can create a robust methodology for identifying OmniAb entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. OmniAb analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. OmniAb analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

OmniAb Inc stock analysis indicators help investors evaluate how OmniAb stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading OmniAb shares will generate the highest return on investment. By understating and applying OmniAb stock analysis, traders can identify OmniAb position entry and exit signals to maximize returns.

When running OmniAb's price analysis, check to measure OmniAb's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OmniAb is operating at the current time. Most of OmniAb's value examination focuses on studying past and present price action to predict the probability of OmniAb's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OmniAb's price. Additionally, you may evaluate how the addition of OmniAb to your portfolios can decrease your overall portfolio volatility.